Online and face-to-face programmes to suit your CPD needs, apply now for September 2018
Page URL: https://www.bionews.org.uk/page_95388

Scientists developing blood test to detect five early-stage cancers

15 February 2016
Appeared in BioNews 839

A blood test to diagnose common types of cancer is in development after researchers found that five forms of the disease share a telltale chemical signature.

Researchers at the US National Human Genome Research Institute found that tumours in colon, lung, breast, stomach and endometrium share a change in a gene called ZNF154. Knowing that DNA from tumours can circulate in the bloodstream, the team proposes it would be possible to detect this change and diagnose cancer from a standard blood test.

'We have laid the groundwork for developing a diagnostic test, which offers the hope of catching cancer earlier and dramatically improving the survival rate of people with many types of cancer,' said Dr Laura Elnitski, whose research group led the study, published in The Journal of Molecular Diagnostics.

In 2013, the research group analysed cancerous tumours from 13 different organs, and found that DNA methylation was commonly increased at ZNF154 in all tumour types. DNA methylation acts like a chemical 'dimmer switch' on genes: an increase in methylation causes a decrease in gene activity.

The current study focused on the possibility of using the enhanced methylation as a reliable indicator of cancer. The team compared 184 samples from five different tumour types with 34 normal, non-cancerous tissue samples.

'Finding a distinctive methylation-based signature is like looking for a spruce tree in a pine forest,' said Dr Elnitski. 'It's a technical challenge to identify, but we found an elevated methylation signature around the gene known as ZNF154 that is unique to tumours.'

Importantly, they found that this genetic change was consistent across the five different types of cancer, suggesting that it could be used as a universal cancer marker. The study also showed that the enhanced methylation was detectable even at very low concentrations in the blood, meaning that a blood test could be used to identify cancer from early-stage tumours.

Currently, diagnostic tools for cancer are reliant on physical examination, internal imaging and biopsies. Where blood tests are used, they are specific to a certain cancer type and require prior knowledge of suspected cancer.

Using a broader and more sensitive approach, as is hoped for the new blood test, would not only be less invasive, but also more likely to detect cancer at an earlier stage, when treatment is more effective.

The researchers are now focusing on developing the blood test as a diagnostic tool. They will need to confirm whether it outperforms existing methods of screening and diagnosis, notes NHS Choices. Characterising the rate at which it indicates cancer is present when the disease is not there – or misses cancer when it is present – will also be highly important.

'Their method of detecting this is very sensitive,' Professor Samuel Janes, honorary medical adviser to the British Lung Foundation, told The Telegraph. He added: 'We will have to wait and see if this actually works.'

SOURCES & REFERENCES
Blood test to spot five deadly cancers could prevent thousands of deaths
The Telegraph |  5 February 2016
Hope that blood test 'could diagnose five types of cancer'
NHS Choices |  8 February 2016
NIH researchers identify striking genomic signature shared by five types of cancer
NIH (press release) |  5 February 2016
Pan-Cancer Epigenetic Signature Readable in Circulating Tumor DNA
Genetic Engineering & Biotechnology News |  5 February 2016
Robust Detection of DNA Hypermethylation of ZNF154 as a Pan-Cancer Locus with in Silico Modeling for Blood-Based Diagnostic Development
The Journal of Molecular Diagnostics |  5 February 2016
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
2 May 2017 - by Dr Loredana Guglielmi 
Blood tests for tumour DNA could predict relapse of the most common type of lung cancer up to one year before clinical signs show up on patient's scans...
24 April 2017 - by Meghna Kataria 
A blood test could swiftly detect gene mutations found in lung cancer, allowing faster commencement of treatment...
26 September 2016 - by Ebtehal Moussa 
A new gene therapy technique using microRNAs has successfully prevented the spread of breast cancer in mice...
12 September 2016 - by Meetal Solanki 
A blood test costing only £35 could help in the early diagnosis of oesophageal cancer and could be available in five years' time...
9 May 2016 - by Rachel Siden 
Adding more genes to existing multi-gene panels that test for breast and ovarian cancer risk offers little clinical benefit, a study says...
21 March 2016 - by Hannah Somers 
Scientists say they have been able to detect multiple diseases, including pancreatic cancer, multiple sclerosis and type 1 diabetes, by analysing fragments of DNA in the bloodstream...
9 November 2015 - by Kirsty Oswald 
Researchers have identified the genetic mutations that drive resistance to the hormone therapy abiraterone in patients with advanced prostate cancer...
9 November 2015 - by Ayala Ochert 
Scientists say it may be possible to track the progress of cancer – and cancer treatment – in real time from fragments of tumour DNA that are shed into the bloodstream...
14 September 2015 - by Isobel Steer 
A US startup called Pathway Genomics has launched the first commercial 'liquid biopsy' to identify cancerous mutations via a blood test...
1 September 2015 - by Hannah Somers 
Scientists have developed a blood test that can predict several months in advance which breast cancer patients will relapse.
20 July 2015 - by Ceri Durham 
Abnormal results from a non-invasive prenatal test for fetal chromosome abnormality may indicate the presence of previously undetected cancers in some mothers....
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.